Chicago, IL · Founded 2017 · Privately Held (backing)
Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.
Last reported valuation
$39.0M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
Early Stage VC
Dec 2024
Team — not yet on record
No current team members for SimBioSys are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SimBioSys with a free account
·The complete investor list: 11 names
·Watch SimBioSys: the Monday email on marks, rounds and moves
